Pharmacology of Heparin and Related Drugs: An Update

Фармакология гепарина и родственных препаратов: обновленный обзор
R. Lever, Barbara Mulloy, Clive Peter Page, John Hogwood, Elaine Gray
2023-02-15

AntithrombinAntithrombotic therapyHeparinImmunothrombosisNeutrophil extracellular traps
Heparin has been used extensively as an antithrombotic and anticoagulant for close to 100 years. This anticoagulant activity is attributed mainly to the pentasaccharide sequence, which potentiates the inhibitory action of antithrombin, a major inhibitor of the coagulation cascade. More recently it has been elucidated that heparin exhibits anti-inflammatory effect via interference of the formation of neutrophil extracellular traps and this may also contribute to heparin's antithrombotic activity. This illustrates that heparin interacts with a broad range of biomolecules, exerting both anticoagulant and nonanticoagulant actions. Since our previous review, there has been an increased interest in these nonanticoagulant effects of heparin, with the beneficial role in patients infected with SARS2-coronavirus a highly topical example. This article provides an update on our previous review with more recent developments and observations made for these novel uses of heparin and an overview of the development status of heparin-based drugs. SIGNIFICANCE STATEMENT: This state-of-the-art review covers recent developments in the use of heparin and heparin-like materials as anticoagulant, now including immunothrombosis observations, and as nonanticoagulant including a role in the treatment of SARS-coronavirus and inflammatory conditions.
1
Heparin also exerts anti-inflammatory effects by interfering with neutrophil extracellular trap formation, potentially contributing to its antithrombotic activity.
2
Heparin interacts with diverse biomolecules and produces both anticoagulant and nonanticoagulant biological effects.
3
Heparin’s anticoagulant activity is primarily mediated by its pentasaccharide sequence, which potentiates antithrombin inhibition of the coagulation cascade.
4
Recent research increasingly emphasizes heparin’s nonanticoagulant applications, including potential benefits in SARS-coronavirus infection and inflammatory conditions.
5
The review summarizes recent developments in heparin-like drugs for anticoagulation, immunothrombosis, and nonanticoagulant therapeutic applications.

Heparin and heparin-related drugs and materials

Their anticoagulant and nonanticoagulant actions, including antithrombotic, anti-inflammatory, immunothrombotic, and therapeutic effects, and the development of heparin-based drugs

Publication Details
Publication Date
2023-02-15
Journal
Publisher
ISSN
Cited by
133
Access Type
Author Information
Authors
R. Lever
Barbara Mulloy
Clive Peter Page
John Hogwood
Elaine Gray
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%